Six essential considerations before commercial launch

Pharmaceutical supply chains are growing in complexity and have been tested in unprecedented ways over the course of the COVID-19 pandemic. Emerging technologies, approvals of increasingly complex and personalized biopharmaceuticals and globalization have all contributed to new challenges in storing and transporting pharmaceutical products.

These trends are reshaping how drug manufacturers plan their logistics and distribution strategies when launching a product.

Our checklist explores and defines these six essential qualities that a manufacturer should look for in a specialty logistics partner:

1. Favors global end-to-end capability with local knowledge
2. Ensures you can manage the cold-chain requirements of more complex low volume therapies
3. Utilizes data to increase visibility
4. Builds risk mitigation strategies
5. Accelerates speed to market
6. Has multiple contingencies in place